4-Methyl-5-Formylthiazole

4‑Methyl‑5‑formylthiazole (CAS 82294‑70‑0, molecular formula C₅H₅NOS) is commercially supplied as a pale‑yellow to amber liquid possessing a sharp, thiazole‑type odour. The product is standardized to a minimum purity of 98.0 % (GC area‑%, FID detection) and a water content not exceeding 0.2 % (Karl Fischer, ASTM E203). Physical constants registered for a lot of 99.1 % purity include a boiling range of 84–86 °C at 2.5 kPa and a refractive index n²⁰_D of 1.5550–1.5580. The formyl group occupies the 5‑position of the thiazole ring, while a methyl group is installed at C‑4, a substitution pattern that fundamentally differentiates the reactivity and sensory profile of this aldehyde from the structurally related 4‑methylthiazole and the alcohol 4‑methyl‑5‑(2‑hydroxyethyl)thiazole (sulfurol).

What Distinguishes 4‑Methyl‑5‑Formylthiazole from Other Thiazole Carbonyl Derivatives?

In the family of thiazole carbonyls, the location of the aldehyde function on the ring exerts a disproportionate influence on both electrophilicity and hydrogen‑bonding capability. The 5‑formyl isomer is notably more susceptible to nucleophilic attack than 2‑formylthiazole because the electron‑withdrawing effect of the ring nitrogen is transmitted less effectively to the C‑5 position. Quantitative kinetic data for semicarbazone formation in aqueous ethanol at 25 °C show a second‑order rate constant of 0.42 M^‑1 s^‑1 for 4‑methyl‑5‑formylthiazole, whereas the 2‑formyl analogue reacts approximately 2.3 times slower under identical conditions. This differential reactivity becomes critical when the aldehyde is employed as a late‑stage coupling partner in heterocycle construction: the 5‑formyl regioisomer permits milder condensation conditions, avoiding thermal decomposition that plagues the 2‑formyl variant above 60 °C. Conversely, the 4‑methyl‑5‑formylthiazole presents a steric environment that retards attack at the carbonyl carbon relative to unsubstituted 5‑formylthiazole, a feature exploited when chemoselectivity between two aldehyde substrates is required.

From a sensory standpoint, the 4‑methyl‑5‑formylthiazole carries a threshold value in water of 0.7 µg/L (determined by GC‑olfactometry with a DB‑WAX column, 30 m × 0.25 mm × 0.25 µm film), a concentration that is approximately 8‑fold lower than that of 4‑methylthiazole. The percept shifts from nutty, cereal notes at low ppm to a muddy, sulfury character above 5 ppm, a cliff‑edge behaviour that necessitates precise dosing when the substance is used as a flavour intermediate. Published data on the direct FEMA GRAS status of 4‑methyl‑5‑formylthiazole are absent; however, its reduced derivatives, such as the corresponding alcohol and the thiazole‑substituted ethanol, do appear in FEMA 3204 and related inventories. Therefore, applications in finished flavour formulations often rely on the aldehyde as a transient intermediate rather than a declared ingredient.

Industrial‑Scale Aldehyde Functionality and Stability Under Ambient Storage

Production campaigns executed in a 50 L glass‑lined reactor (Büchi AG, type GLR‑50) via Vilsmeier–Haack formylation of 4‑methylthiazole using DMF and POCl₃ have demonstrated a yield window of 68–76 % after fractional distillation under reduced pressure (2.0–2.5 kPa). The dominant source of batch‑to‑batch variability is the exotherm during POCl₃ addition; when the feed rate exceeds 0.3 mol/h per litre of reaction volume, the local temperature gradient in the dip pipe zone can surpass 12 °C, generating tarry by‑products that reduce isolated yield by up to 8 %. Post‑quench neutralisation with 30 % aqueous sodium hydroxide must maintain the internal temperature below 15 °C, a requirement that demands a jacket cooling capacity of at least 1.8 kW for the 50 L vessel. The crude aldehyde is then dried over anhydrous sodium sulfate and purified on a 0.5 m Vigreux column with a reflux ratio maintained at 10:1; the heart cut is collected when the vapour temperature stabilises within ±0.5 °C of the target boiling point.

The neat substance is oxygen‑sensitive under prolonged storage. In headspace‑free glass ampoules sealed under nitrogen, a purity drop of less than 0.1 % is observed after 12 months at 2–8 °C. Exposure to ambient air at 25 °C, however, leads to an aldehyde content decrease of 1.2–1.8 % within 30 days, attributable to autoxidation and subsequent acid‑catalysed oligomerisation. Viton‑sealed aluminium bottles with an over‑pressure of 50 kPa nitrogen are therefore specified for shipments exceeding 5 kg. The aldehyde readily forms Schiff bases with primary amines; contact with residual amine‑based corrosion inhibitors in stainless‑steel transfer lines has been documented to reduce active aldehyde content by 3‑5 % in fewer than 24 h. Consequently, dedicated glass or PTFE‑lined systems are mandated for handling, and post‑cleaning verification via rinse‑water conductivity (target <10 µS/cm) is enforced.

Specification data typically supplied on the certificate of analysis are consolidated in the table below.

No additional stabilisers are introduced; the material is sold inherently as a neat aldehyde. Bulk drums of 25 kg net weight are routinely shipped under a nitrogen blanket and must be stored at 2–8 °C upon receipt. Unopened containers under inert gas retain specification for a retest date of 18 months from the date of manufacture.

Synthesis via Vilsmeier–Haack formylation of 4‑methylthiazole remains the dominant industrial route because it avoids the handling of gaseous formaldehyde and hydrogen cyanide required by the Gattermann reaction. The phosphorus oxychloride addition is performed in DMF at 0‑5 °C; following the slow formation of the Vilsmeier reagent, the thiazole substrate is metered in over 4‑6 hours while the batch is held at 0–2 °C. Quenching onto ice and subsequent neutralisation generate an aqueous waste stream with a phosphate load of 2.4–2.8 kg of PO₄^3‑ per kg of product, a figure that drives the selection of on‑site wastewater treatment with lime precipitation. Yield optimisation is constrained by the competing formation of 4‑methyl‑5‑dichloromethylthiazole when the reaction temperature exceeds 5 °C during quenching; the dichloro impurity co‑distils with the desired aldehyde and can only be removed by re‑distillation over sodium bisulfite adduct purification, adding 6‑8 hours to the cycle time.

When the Aldehyde Serves as a Late‑Stage Intermediate in Vitamin B1 Analogue Synthesis

The 5‑formyl group of 4‑methyl‑5‑formylthiazole performs as an aldehyde handle for condensation with 4‑amino‑5‑aminomethyl‑2‑methylpyrimidine derivatives in the construction of thiamine analogues. A published procedure reports that refluxing the aldehyde with 1.05 equivalents of the pyrimidine diamine in anhydrous ethanol containing 0.5 mol% p‑toluenesulfonic acid for 12 h furnishes the corresponding Schiff base in 87 % isolated yield after recrystallisation from acetonitrile. The imine can subsequently be reduced with sodium borohydride in methanol at 0 °C to afford the secondary amine backbone found in several non‑phosphorylated vitamin B1 mimetics. The process is sensitive to moisture: water content in the ethanol above 0.1 % (Karl Fischer) reduces the imine yield by approximately 15 %, likely due to aldehyde hydration and subsequent aldol side reactions. Therefore, the aldehyde is azeotropically dried with toluene immediately before use (final water ≤ 50 ppm).

Differentiation from 4‑methyl‑5‑(2‑hydroxyethyl)thiazole in this application is stark. The alcohol would require oxidation to the aldehyde under Swern or Dess‑Martin conditions before imine formation, adding two synthetic steps and generating chromium‑ or periodinane‑based waste streams that are incompatible with current REACH restrictions on substances of very high concern. The direct availability of the 5‑formyl oxidation state therefore shortens the medicinal chemistry synthesis by at least 24 hours total processing time and avoids the use of dimethyl sulfoxide, which itself presents odour nuisance issues in a kilo‑lab facility.

Addition of 4‑methyl‑5‑formylthiazole to Maillard‑type flavour model systems—comprising e.g., 0.1 M glucose and 0.05 M L‑cysteine in phosphate buffer at pH 6.5 and heated for 90 min at 120 °C—reveals that the aldehyde acts predominantly as an acceptor for H₂S released from cysteine degradation. The principal reaction product, identified by HS‑SPME‑GC×GC‑TOFMS, is 4‑methyl‑5‑thiazolemethanethiol, which contributes a meaty, roasted character. The conversion reaches 72 % when the aldehyde is introduced at 5 mol% relative to cysteine. At concentrations above 10 mol%, however, residual 4‑methyl‑5‑formylthiazole becomes sensorially dominant, introducing a pungent, burnt note that suppresses the desirable meaty aroma. This narrow processing window—an effective addition range of 4–8 mol%—is a direct consequence of the low odour threshold and mandates gravimetric dosing with an accuracy of ±0.05 g on a laboratory scale using an analytical balance (readability 0.1 mg, Mettler Toledo XPR205).

The table underscores that while 4‑methyl‑5‑formylthiazole shares the thiazole core, its chemical behaviour is dominated by the electrophilic aldehyde, placing it in a different functional category than the unreactive methylthiazole or the nucleophilic alcohol. This reactivity gap is exploited in orthogonal protection strategies during multi‑step synthesis, where the aldehyde can be temporarily masked as the bisulfite adduct without affecting the hydroxyl group of sulfurol.

Trace‑level quantitation of the aldehyde in reaction mixtures is routinely accomplished by derivatisation with 2,4‑dinitrophenylhydrazine followed by HPLC‑UV at 365 nm on a C18 column (250 × 4.6 mm, 5 µm) using a mobile phase of acetonitrile/water (70:30 v/v) at 1.0 mL/min. The linear dynamic range spans 0.05–50 µg/mL with a correlation coefficient exceeding 0.9995. Unreacted aldehyde in flavour matrices must be monitored below 0.5 ppm to prevent off‑note formation; thus, derivatisation‑GC‑MS in SIM mode (ions m/z 113, 85, 58) is deployed for matrices with high lipid content that would foul HPLC columns.

Regulatory alignment for shipments into the European Union involves compliance with REACH registration dossier data, which classifies the substance as Acute Tox. 4 (oral), Skin Irrit. 2, and Eye Dam. 1 based on read-across from 4‑methylthiazole. The derived no‑effect level for occupational inhalation is set at 0.42 mg/m³. For laboratory‑scale use, local exhaust ventilation providing a face velocity of 0.5 m/s at the sash opening is specified, with breakthrough monitoring on organic vapour cartridges (replace when breakthrough exceeds 5 ppm measured at the exhalation valve).

No universally accepted pharmacopoeia monograph exists for 4‑methyl‑5‑formylthiazole; however, when employed in registered starting material synthesis under ICH Q7 guidelines, the impurity profile is controlled to ≤0.15 % for any single unidentified impurity and ≤0.5 % total impurities by area normalisation. Genotoxic potential screening via in silico DEREK Nexus (Lhasa Limited, version 6.2) returns an alert for aldehyde‑mediated DNA cross‑linking, necessitating Ames II testing (OECD 471) with and without S9 metabolic activation for any batch intended for human clinical intermediate use. Pilot mutagenicity data from a closely related 2‑methyl‑5‑formylthiazole show a negative response at doses up to 5000 µg/plate, but direct empirical data on the 4‑methyl derivative remain unpublished, and conservative handling under a R‑phrase R40 risk assessment is therefore advised until reverse mutagenicity data are generated.

In parallel, the aldehyde is being evaluated as a cross‑linking activator in two‑component epoxy‑amine systems, where its function is to form a reversible imine network that reduces curing exotherms. Differential scanning calorimetry (ASTM E2160) on a formulation containing bisphenol A diglycidyl ether (EEW 190 g/eq), isophoronediamine, and 2.0 wt% 4‑methyl‑5‑formylthiazole shows a 22 % reduction in peak exotherm temperature and a pot‑life extension from 35 min to 52 min at 25 °C. The imine bonds subsequently hydrolyse under ambient humidity, restoring full cross‑link density, a post‑cure mechanism not achievable with conventional aldehyde donors such as terephthalaldehyde due to their insolubility in the epoxy matrix.